123 related articles for article (PubMed ID: 28847124)
1. Letter to the Editor Regarding "Effects of Oral Glibenclamide on Brain Contusion Volume and Functional Outcome of Patients with Moderate and Severe Traumatic Brain Injuries: A Randomized Double-Blind Placebo-Controlled Clinical Trial".
Garg K; Singh PM
World Neurosurg; 2017 Sep; 105():1020. PubMed ID: 28847124
[No Abstract] [Full Text] [Related]
2. In Reply to the Letter to the Editor Regarding "Effects of Oral Glibenclamide on Brain Contusion Volume and Functional Outcome of Patients with Moderate and Severe Traumatic Brain Injuries: A Randomized Double-Blind Placebo-Controlled Clinical Trial".
Khalili H; Derakhshan N; Ghaffarpasand F; Heydari ST
World Neurosurg; 2017 Sep; 105():1021. PubMed ID: 28847125
[No Abstract] [Full Text] [Related]
3. Effects of Oral Glibenclamide on Brain Contusion Volume and Functional Outcome of Patients with Moderate and Severe Traumatic Brain Injuries: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
Khalili H; Derakhshan N; Niakan A; Ghaffarpasand F; Salehi M; Eshraghian H; Shakibafard A; Zahabi B
World Neurosurg; 2017 May; 101():130-136. PubMed ID: 28185976
[TBL] [Abstract][Full Text] [Related]
4. Effects of atorvastatin on brain contusion volume and functional outcome of patients with moderate and severe traumatic brain injury; a randomized double-blind placebo-controlled clinical trial.
Farzanegan GR; Derakhshan N; Khalili H; Ghaffarpasand F; Paydar S
J Clin Neurosci; 2017 Oct; 44():143-147. PubMed ID: 28688622
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance Imaging Pilot Study of Intravenous Glyburide in Traumatic Brain Injury.
Eisenberg HM; Shenton ME; Pasternak O; Simard JM; Okonkwo DO; Aldrich C; He F; Jain S; Hayman EG
J Neurotrauma; 2020 Jan; 37(1):185-193. PubMed ID: 31354055
[TBL] [Abstract][Full Text] [Related]
6. Glibenclamide for Brain Contusions: Contextualizing a Promising Clinical Trial Design that Leverages an Imaging-Based TBI Endotype.
Jha RM; Simard JM
Neurotherapeutics; 2023 Oct; 20(6):1472-1481. PubMed ID: 37306928
[TBL] [Abstract][Full Text] [Related]
7. Contusion Progression Following Traumatic Brain Injury: A Review of Clinical and Radiological Predictors, and Influence on Outcome.
Adatia K; Newcombe VFJ; Menon DK
Neurocrit Care; 2021 Feb; 34(1):312-324. PubMed ID: 32462411
[TBL] [Abstract][Full Text] [Related]
8. Response to letter to the editor: The effects of amantadine on traumatic brain injury outcome: a double-blind, randomized, controlled, clinical trial.
Fattahi A; Taheri M
Brain Inj; 2019; 33(3):399-400. PubMed ID: 30507326
[No Abstract] [Full Text] [Related]
9. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial.
Sheth KN; Elm JJ; Molyneaux BJ; Hinson H; Beslow LA; Sze GK; Ostwaldt AC; Del Zoppo GJ; Simard JM; Jacobson S; Kimberly WT
Lancet Neurol; 2016 Oct; 15(11):1160-9. PubMed ID: 27567243
[TBL] [Abstract][Full Text] [Related]
10. Derivation of a Predictive Score for Hemorrhagic Progression of Cerebral Contusions in Moderate and Severe Traumatic Brain Injury.
Allison RZ; Nakagawa K; Hayashi M; Donovan DJ; Koenig MA
Neurocrit Care; 2017 Feb; 26(1):80-86. PubMed ID: 27473209
[TBL] [Abstract][Full Text] [Related]
11. Post-operative expansion of hemorrhagic contusions after unilateral decompressive hemicraniectomy in severe traumatic brain injury.
Flint AC; Manley GT; Gean AD; Hemphill JC; Rosenthal G
J Neurotrauma; 2008 May; 25(5):503-12. PubMed ID: 18346002
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
[TBL] [Abstract][Full Text] [Related]
13. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of DHEP-heparin plaster in reducing pain in mild-to-moderate muscle contusions: a double-blind, randomized trial.
Hoffmann P; Kopačka P; Gugliotta B; Rovati S
Curr Med Res Opin; 2012 Aug; 28(8):1313-21. PubMed ID: 22762346
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety assessment of acute sports-related traumatic soft tissue injuries using a new ibuprofen medicated plaster: results from a randomized controlled clinical trial.
Predel HG; Connolly MP; Bhatt A; Giannetti B
Phys Sportsmed; 2017 Nov; 45(4):418-425. PubMed ID: 28926295
[TBL] [Abstract][Full Text] [Related]
16. Glibenclamide reduces secondary brain damage after experimental traumatic brain injury.
Zweckberger K; Hackenberg K; Jung CS; Hertle DN; Kiening KL; Unterberg AW; Sakowitz OW
Neuroscience; 2014 Jul; 272():199-206. PubMed ID: 24792709
[TBL] [Abstract][Full Text] [Related]
17. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
[TBL] [Abstract][Full Text] [Related]
18. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury.
Wright DW; Kellermann AL; Hertzberg VS; Clark PL; Frankel M; Goldstein FC; Salomone JP; Dent LL; Harris OA; Ander DS; Lowery DW; Patel MM; Denson DD; Gordon AB; Wald MM; Gupta S; Hoffman SW; Stein DG
Ann Emerg Med; 2007 Apr; 49(4):391-402, 402.e1-2. PubMed ID: 17011666
[TBL] [Abstract][Full Text] [Related]
19. Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.
Kluger Y; Riou B; Rossaint R; Rizoli SB; Boffard KD; Choong PI; Warren B; Tillinger M
Crit Care; 2007; 11(4):R85. PubMed ID: 17686152
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.
Ashman TA; Cantor JB; Gordon WA; Spielman L; Flanagan S; Ginsberg A; Engmann C; Egan M; Ambrose F; Greenwald B
Arch Phys Med Rehabil; 2009 May; 90(5):733-40. PubMed ID: 19406291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
